DUBLIN–(BUSINESS WIRE)–The “Myelofibrosis – Epidemiology Forecast – 2034” report has been added to ResearchAndMarkets.com’s offering. The report delivers an in-depth understanding of the myelofibrosis, historical and forecasted epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Prominent clinical features in myelofibrosis include anemia, hepatosplenomegaly, and constitutional symptoms including fatigue, night sweats, low-grade fever,
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/myelofibrosis-epidemiology-forecast-research-2020-2034-researchandmarkets-com/
